RT Journal Article
SR Electronic
T1 Methylphenidate. An update on extended-release formulations
JF Neurosciences Journal
JO Neurosciences (Riyadh)
FD Prince Sultan Military Medical City
SP 3
OP 7
VO 12
IS 1
A1 Zolezzi, Monica
YR 2007
UL http://nsj.org.sa/content/12/1/3.abstract
AB Methylphenidate remains the mainstay of pharmacological management in attention deficit hyperactivity disorder (ADHD). Despite having been available for over half a century, methylphenidates original formulation has been modified with the main purpose of extending its duration of action. This article will present a brief review of how these new formulations vary and how these should be selected, considering the evidence available on their effectiveness and on the individual needs of the patient.